The cumulative methylation status at significant CpG sites of CYP24A1 was negatively associated with the risk of colorectal cancer, with an aOR of 0.19 (95% CI, 0.09–0.40; P < 0.001). The gene discussed is CYP24A1; the disease is colorectal cancer.